Following these lines of evidence, a mouse MC38 colon adenocarcinoma cell line that was made resistant to anti-PD-1, transcriptomic profiles revealed that Gpnmb was significantly upregulated in anti-PD-1 therapy-resistant compared to -sensitive tumors. Here, GPNMB is linked to colon adenocarcinoma.